Reimagining Gynae Health: From Period Pain to Precision Diagnostics

Despite comprising half the population, women remain significantly underrepresented in medical research and underserved in healthcare innovation. Most modern medications are developed using male physiology as the baseline, and tools like the speculum, unchanged since antiquity, remain standard in gynaecological care.

In this keynote, Valentina Milanova, founder and CEO of Daye, will explore how Daye is pioneering a new clinical standard in women’s health—from developing the world’s first Pain-Relieving and Diagnostic Tampons, to building an extensive medical database that’s redefining how we understand and treat conditions like cervical cancer, endometriosis, and vaginal infections.

Valentina will walk the audience through Daye’s product journey—from novel IP and in-house manufacturing, to global launches and AI-assisted diagnostics. She will also highlight the path toward sustainable, inclusive medical devices and how Daye is leveraging its technologies in underserved markets.

This is a call to action for pharma, investors, and policymakers: to support evidence-based, female-first innovation and close the gender health gap for good.